Carolina Remke

Freiburg, Germany, April 08, 2026 — CorTec GmbH, a pioneer in fully implantable brain-computer interfaces (BCI), today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the company’s  Brain Interchange™ system. The designation covers the use of direct cortical electrical stimulation to support motor recovery in people living with […]

The University of Washington shared the inspiring story of a stroke patient who regained movement thanks to a pioneering brain implant technology developed by CorTec.   After two strokes, Matt Kidd’s left side was almost completely paralyzed. Years of therapy brought little progress, until he became part of a clinical trial at the University of

A Strengthened Leadership Team to Accelerate Growth and Innovation   CorTec GmbH, a pioneer in active implantable technologies and Brain-Computer Interface (BCI) systems, is pleased to announce the appointment of Dr. Frank Desiere as its new Chief Executive Officer (CEO). This significant leadership milestone highlights CorTec’s commitment to driving innovation and growth in the rapidly

CorTec GmbH, a leader in innovative implantable technologies, is pleased to announce a strategic partnership with Heraeus Medevio, based in Minneapolis, USA. This collaboration aims to support customers in the neuromodulation sector, from concept and small series production (CorTec) to large series production (Medevio). Together, the companies will deliver next-generation medical devices and drive innovation

German medical technology innovator poised to make waves after implantation of a brain chip by Neuralink in a human trial As it prepares for the next stage of its groundbreaking device for the treatment of stroke, CorTec GmbH, a pioneering German medical technology company, is poised to make significant strides in the field of neurotechnology.